Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
There are no standards requiring radiologists to report on the presence of BACs, even though up to half of referring providers have indicated they would prefer to be made aware of the finding.
Breast artery calcifications are already visible when radiologists review mammograms, but nothing typically happens with them. Researchers aimed to see if AI could help translate those findings into an easy-to-understand cardiovascular risk score.
Despite the great progress that has been made toward the clinical implementation of AI, new data caution against trusting the technology as a single reader in certain settings.
In a new video, Evans Pappas, MD, and Sujith Kalathiveetil, MD, both of Duly Health and Care in suburban Chicago, explain the shift toward office-based cardiac CT evaluations and the role of FFR-CT.
The bills update the ages at which insurance carriers are required to cover screening mammograms and add language that includes tomosynthesis in the definition of mammographic screening.
Research published recently in BMC Pulmonary Medicine examined associations between findings on low dose computed tomography screenings and other conditions, such as cardiovascular, respiratory and oncologic diseases.
The software was trained using more than 700 images and achieved a breast density classification accuracy of 89%, experts recently shared in Radiology: Artificial Intelligence.
Women with breast arterial calcifications are 51% more likely to develop heart disease or have a stroke, experts explained recently in Circulation: Cardiovascular Imaging.
In an exclusive video, Stacey Wolfson, MD, and Beatriu Reig, MD, MPH, from the NYU Grossman School of Medicine, discuss the findings of their new analysis.
There are not yet consensus-based guidelines available for screening women with dense breast tissue, so researchers at Mayo Clinic recently developed a set of recommendations regarding supplemental screening.